Response to 'Dai W et al. Am J Cancer Res 2015;5(10):3270-3275' from the makers of nintedanib

Am J Cancer Res. 2016 Jul 1;6(7):1547-8. eCollection 2016.

Authors

Claudia-Nanette Gann¹, Nassim Morsli², Xiaoxiang Chen³, José Barrueco⁴

Affiliations

¹ Boehringer Ingelheim GmbH Ingelheim, Germany.
² Boehringer Ingelheim Corporation Reims, France.
³ Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.Shanghai, China; Current Address: Boehringer Ingelheim GmbHIngelheim, Germany.
⁴ Boehringer Ingelheim Pharmaceuticals Ridgefield, CT, USA.

PMID: 27508096
PMCID: PMC4969403

No abstract available

Publication types

Comment